Paper39249555
Cardioprotection strategies for anthracycline cardiotoxicity.
Moreno-Arciniegas A and 4 others. Basic Res Cardiol, 2025. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Cardioprotection strategies for anthracycline cardiotoxicity. Papers, record 39249555. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39249555
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anthracyclines | Major topic |
| Cardiotonic Agents | Major topic |
| Heart Diseases | Major topic |
| Antibiotics, Antineoplastic | Major topic |
| Humans | |
| Cardiotoxicity | |
| Animals | |
| Neoplasms |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 945118 | HORIZON EUROPE Framework Programme | PubMed |
Source PubMed
References121
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35343021 | Antiapoptotic and anti-inflammatory effects of Pparγ agonist, pioglitazone, reversed Dox-induced cardiotoxicity through mediating of miR-130a downregulation in C57BL/6 mice. | J Biochem Mol Toxicol | 2022 | https://conductscience.org/library/papers/35343021 | PubMed |
| 2 | 38512567 | Is There a Mitochondrial Protection via Remote Ischemic Conditioning in Settings of Anticancer Therapy Cardiotoxicity? | Curr Heart Fail Rep | 2024 | https://conductscience.org/library/papers/38512567 | PubMed |
| 3 | 33962676 | Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice. | BMC Pharmacol Toxicol | 2021 | https://conductscience.org/library/papers/33962676 | PubMed |
| 4 | 29336940 | Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. | Arch Biochem Biophys | 2018 | https://conductscience.org/library/papers/29336940 | PubMed |
| 5 | 25988386 | Mitochondria-derived reactive oxygen species play an important role in Doxorubicin-induced platelet apoptosis. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/25988386 | PubMed |
| 6 | 28395011 | Metabolism in cardiomyopathy: every substrate matters. | Cardiovasc Res | 2017 | https://conductscience.org/library/papers/28395011 | PubMed |
| 7 | 32358917 | Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial. | ESC Heart Fail | 2020 | https://conductscience.org/library/papers/32358917 | PubMed |
| 8 | 38724618 | The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity. | Basic Res Cardiol | 2025 | https://conductscience.org/library/papers/38724618 | PubMed |
| 9 | 33983836 | Cardiac Energy Metabolism in Heart Failure. | Circ Res | 2021 | https://conductscience.org/library/papers/33983836 | PubMed |
| 10 | 25948538 | Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. | Circulation | 2015 | https://conductscience.org/library/papers/25948538 | PubMed |
| 11 | 35690107 | Mitotherapy in doxorubicin induced cardiotoxicity: A promising strategy to reduce the complications of treatment. | Life Sci | 2022 | https://conductscience.org/library/papers/35690107 | PubMed |
| 12 | 37397080 | Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic Conditioning. | JACC CardioOncol | 2023 | https://conductscience.org/library/papers/37397080 | PubMed |
| 13 | 39212445 | Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity. | Eur J Heart Fail | 2024 | https://conductscience.org/library/papers/39212445 | PubMed |
| 14 | 37969654 | Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2023 | https://conductscience.org/library/papers/37969654 | PubMed |
| 15 | 33438065 | Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity. | Cardiovasc Toxicol | 2021 | https://conductscience.org/library/papers/33438065 | PubMed |
| 16 | 29766336 | Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway. | Cardiovasc Drugs Ther | 2018 | https://conductscience.org/library/papers/29766336 | PubMed |
| 17 | 30784671 | Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity. | J Am Coll Cardiol | 2019 | https://conductscience.org/library/papers/30784671 | PubMed |
| 18 | 32699841 | Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice. | JACC CardioOncol | 2019 | https://conductscience.org/library/papers/32699841 | PubMed |
| 19 | 32637985 | Protection from cardiotoxicity of cancer chemotherapy: a novel target for remote ischaemic conditioning? | Cardiovasc Res | 2021 | https://conductscience.org/library/papers/32637985 | PubMed |
| 20 | 24616701 | The role of iron in anthracycline cardiotoxicity. | Front Pharmacol | 2014 | https://conductscience.org/library/papers/24616701 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737759 | Nutritional Prevention of Oxidative Stress-Induced Cardiotoxicity in Pediatric Cardio-Oncology: Molecular Mechanisms and Translational Perspectives-A Narrative Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737759 | PubMed |
| 42700271 | Multifunctional cardiac tropin I sensing using MWCNTs-COOH/PoPD composites for integrated warning, screening and protection assessment of traditional Chinese medicine-induced cardiotoxicity. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/42700271 | PubMed |
| 42651365 | Risk-Adaptive Cardio-Oncology Rehabilitation: A Narrative Review of Exercise Prescription, Multimodal Monitoring, and Implementation Pathways. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42651365 | PubMed |
| 42356463 | Carvedilol Exerts Cardioprotective Effects Against Doxorubicin Toxicity via Autophagy Modulation and Energetics Restoration. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356463 | PubMed |
| 42133079 | Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42133079 | PubMed |
| 41686252 | Remote ischemic conditioning protects against anthracycline cardiotoxicity without impairing its antitumor activity. | Basic Res Cardiol | 2026 | https://conductscience.org/library/papers/41686252 | PubMed |
| 41537578 | Cardioprotective SNPs in SLC28A3 and lncRNA SLC28A3-AS1 result in transcriptional changes and alternative splicing to reduce doxorubicin cytotoxicity. | Hum Mol Genet | 2026 | https://conductscience.org/library/papers/41537578 | PubMed |
| 41528064 | Anthracycline cardiotoxicity: role of metabolic vulnerability induced by cardiac pressure overload. | Eur Heart J | 2026 | https://conductscience.org/library/papers/41528064 | PubMed |
| 41466436 | Sustained mesenchymal reprogramming of endothelial cells after completion of chemotherapy. | Cardiooncology | 2025 | https://conductscience.org/library/papers/41466436 | PubMed |
| 41331489 | Omega-3 fatty acids and chemotherapy-induced toxicities: mechanisms and emerging evidence with a pediatric focus. | Nutr Metab (Lond) | 2025 | https://conductscience.org/library/papers/41331489 | PubMed |
| 41244136 | Early detection of chemotherapy-induced cardiotoxicity in lymphoma patients: RT-3DE/2D-STI and predictive role of LAEFa/LASr. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/41244136 | PubMed |
| 41101779 | Chemotherapy-induced cardiotoxicity in breast cancer: mechanisms, diagnostic advances, and emerging protective strategies. | Am J Physiol Heart Circ Physiol | 2025 | https://conductscience.org/library/papers/41101779 | PubMed |
| 40918193 | MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40918193 | PubMed |
| 40789308 | Cardiovascular risk in cancer patients: initial experience from a cardio-oncology clinic in Mexico. | Arch Cardiol Mex | 2025 | https://conductscience.org/library/papers/40789308 | PubMed |
| 40572494 | Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity. | Molecules | 2025 | https://conductscience.org/library/papers/40572494 | PubMed |
| 40403110 | Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases. | Circ Res | 2025 | https://conductscience.org/library/papers/40403110 | PubMed |
| 39967204 | SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial Energetics. | JACC CardioOncol | 2025 | https://conductscience.org/library/papers/39967204 | PubMed |
| 39681732 | Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop. | Basic Res Cardiol | 2025 | https://conductscience.org/library/papers/39681732 | PubMed |
| 39621070 | The cardio-oncologic burden of breast cancer: molecular mechanisms and importance of preclinical models. | Basic Res Cardiol | 2025 | https://conductscience.org/library/papers/39621070 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39249555
GET https://conductscience.org/api/papers/v1/39249555/references?page=2